Matches in SemOpenAlex for { <https://semopenalex.org/work/W2357180813> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W2357180813 endingPage "303" @default.
- W2357180813 startingPage "301" @default.
- W2357180813 abstract "OBJECTIVE: Ambroxol induces the synthesis of surfactant in lung alveolar type II cells. Some studies have shown its effectiveness for the prevention of respiratory distress syndrome (RDS) in preterm infants. This study aimed to compare the efficacy of two different ways of ambroxol administration, ie, intravenous injection and atomizing inhalation, for the prevention of RDS in preterm infants. METHODS: A total of 125 preterm infants born between 28-37 weeks of gestation were randomly assigned into three groups: Intravenous and Atomizing ambroxol treatment groups (n=40 each) or Control group (n=45). The Intravenous group was injected with 15 mg/kg of ambroxol through the umbilical vein immediately after birth and then received 30 mg/kg of ambroxol daily for 2 days by intravenous drip. The Atomizing group was administered with 30 mg/kg of ambroxol daily for 2 days by atomizing inhalation immediately after birth. The Control group received no ambroxol treatment. The incidences of RDS and complications as well as the blood gas results 6 hrs after birth were compared among the three groups. RESULTS: The incidence of RDS was 7.5%, 5.0% and 24.4% in the Intravenous, Atomizing and Control groups respectively. There were no significant differences in the incidence of RDS between the two ambroxol treatment groups. However, the incidence of RDS in the two treatment groups were noticeably lower than in the Control group (P < 0.05). The blood gas results did not show significant differences between the two ambroxol treatment groups but both groups demonstrated improved blood gas results compared with the Control group at 6 hrs after birth (P < 0.05). The incidence of complications, such as pulmonary hemorrhage, respiratory failure, intraranial hemorrhage, in the two ambroxol treatment groups was reduced compared with the Control group (P < 0.05), but there were no differences between the two ambroxol groups. CONCLUSIONS: Early administration of either intravenous or atomizing ambroxol can produce a positive efficacy for the prevention of RDS in preterm infants. The two different ways of administration seem to result in a similar efficacy in the prevention of RDS." @default.
- W2357180813 created "2016-06-24" @default.
- W2357180813 creator A5017339065 @default.
- W2357180813 creator A5019812451 @default.
- W2357180813 creator A5020517616 @default.
- W2357180813 date "2006-08-01" @default.
- W2357180813 modified "2023-09-24" @default.
- W2357180813 title "Efficacy of intravenous or atomizing ambroxol for prevention of respiratory distress syndrome in preterm infants" @default.
- W2357180813 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16923362" @default.
- W2357180813 hasPublicationYear "2006" @default.
- W2357180813 type Work @default.
- W2357180813 sameAs 2357180813 @default.
- W2357180813 citedByCount "1" @default.
- W2357180813 crossrefType "journal-article" @default.
- W2357180813 hasAuthorship W2357180813A5017339065 @default.
- W2357180813 hasAuthorship W2357180813A5019812451 @default.
- W2357180813 hasAuthorship W2357180813A5020517616 @default.
- W2357180813 hasConcept C120665830 @default.
- W2357180813 hasConcept C121332964 @default.
- W2357180813 hasConcept C141983124 @default.
- W2357180813 hasConcept C2776330663 @default.
- W2357180813 hasConcept C42219234 @default.
- W2357180813 hasConcept C61511704 @default.
- W2357180813 hasConcept C71924100 @default.
- W2357180813 hasConceptScore W2357180813C120665830 @default.
- W2357180813 hasConceptScore W2357180813C121332964 @default.
- W2357180813 hasConceptScore W2357180813C141983124 @default.
- W2357180813 hasConceptScore W2357180813C2776330663 @default.
- W2357180813 hasConceptScore W2357180813C42219234 @default.
- W2357180813 hasConceptScore W2357180813C61511704 @default.
- W2357180813 hasConceptScore W2357180813C71924100 @default.
- W2357180813 hasIssue "4" @default.
- W2357180813 hasLocation W23571808131 @default.
- W2357180813 hasLocation W23571808132 @default.
- W2357180813 hasOpenAccess W2357180813 @default.
- W2357180813 hasPrimaryLocation W23571808131 @default.
- W2357180813 hasRelatedWork W2080642714 @default.
- W2357180813 hasRelatedWork W2348824454 @default.
- W2357180813 hasRelatedWork W2352607151 @default.
- W2357180813 hasRelatedWork W2354593021 @default.
- W2357180813 hasRelatedWork W2355332391 @default.
- W2357180813 hasRelatedWork W2357242388 @default.
- W2357180813 hasRelatedWork W2360364243 @default.
- W2357180813 hasRelatedWork W2361737673 @default.
- W2357180813 hasRelatedWork W2363539707 @default.
- W2357180813 hasRelatedWork W2367302498 @default.
- W2357180813 hasRelatedWork W2372995014 @default.
- W2357180813 hasRelatedWork W2373911203 @default.
- W2357180813 hasRelatedWork W2376068145 @default.
- W2357180813 hasRelatedWork W2387949443 @default.
- W2357180813 hasRelatedWork W2388681406 @default.
- W2357180813 hasRelatedWork W2389407708 @default.
- W2357180813 hasRelatedWork W2392953800 @default.
- W2357180813 hasRelatedWork W2411661421 @default.
- W2357180813 hasRelatedWork W3029967732 @default.
- W2357180813 hasRelatedWork W3030918582 @default.
- W2357180813 hasVolume "8" @default.
- W2357180813 isParatext "false" @default.
- W2357180813 isRetracted "false" @default.
- W2357180813 magId "2357180813" @default.
- W2357180813 workType "article" @default.